These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 12125742)

  • 1. Mitochondrial DNA deletions/rearrangements in parkinson disease and related neurodegenerative disorders.
    Gu G; Reyes PE; Golden GT; Woltjer RL; Hulette C; Montine TJ; Zhang J
    J Neuropathol Exp Neurol; 2002 Jul; 61(7):634-9. PubMed ID: 12125742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isofurans, but not F2-isoprostanes, are increased in the substantia nigra of patients with Parkinson's disease and with dementia with Lewy body disease.
    Fessel JP; Hulette C; Powell S; Roberts LJ; Zhang J
    J Neurochem; 2003 May; 85(3):645-50. PubMed ID: 12694390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIGAR inclusion pathology is specific for Lewy body diseases.
    López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
    Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic midbrain neurons are the prime target for mitochondrial DNA deletions.
    Bender A; Schwarzkopf RM; McMillan A; Krishnan KJ; Rieder G; Neumann M; Elstner M; Turnbull DM; Klopstock T
    J Neurol; 2008 Aug; 255(8):1231-5. PubMed ID: 18604467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nature of mitochondrial DNA deletions in substantia nigra neurons.
    Reeve AK; Krishnan KJ; Elson JL; Morris CM; Bender A; Lightowlers RN; Turnbull DM
    Am J Hum Genet; 2008 Jan; 82(1):228-35. PubMed ID: 18179904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant Twinkle increases dopaminergic neurodegeneration, mtDNA deletions and modulates Parkin expression.
    Song L; Shan Y; Lloyd KC; Cortopassi GA
    Hum Mol Genet; 2012 Dec; 21(23):5147-58. PubMed ID: 22949510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic mitochondrial DNA mutations in early Parkinson and incidental Lewy body disease.
    Lin MT; Cantuti-Castelvetri I; Zheng K; Jackson KE; Tan YB; Arzberger T; Lees AJ; Betensky RA; Beal MF; Simon DK
    Ann Neurol; 2012 Jun; 71(6):850-4. PubMed ID: 22718549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substantia nigra Marinesco bodies are associated with decreased striatal expression of dopaminergic markers.
    Beach TG; Walker DG; Sue LI; Newell A; Adler CC; Joyce JN
    J Neuropathol Exp Neurol; 2004 Apr; 63(4):329-37. PubMed ID: 15099023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease.
    Dölle C; Flønes I; Nido GS; Miletic H; Osuagwu N; Kristoffersen S; Lilleng PK; Larsen JP; Tysnes OB; Haugarvoll K; Bindoff LA; Tzoulis C
    Nat Commun; 2016 Nov; 7():13548. PubMed ID: 27874000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mitochondrial common deletion in Parkinson's disease and related movement disorders.
    Zhang J; Montine TJ; Smith MA; Siedlak SL; Gu G; Robertson D; Perry G
    Parkinsonism Relat Disord; 2002 Jan; 8(3):165-70. PubMed ID: 12039426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease.
    Simon DK; Lin MT; Zheng L; Liu GJ; Ahn CH; Kim LM; Mauck WM; Twu F; Beal MF; Johns DR
    Neurobiol Aging; 2004 Jan; 25(1):71-81. PubMed ID: 14675733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging synucleinopathies.
    Brooks DJ; Tambasco N
    Mov Disord; 2016 Jun; 31(6):814-29. PubMed ID: 26879635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons.
    Zhang J; Perry G; Smith MA; Robertson D; Olson SJ; Graham DG; Montine TJ
    Am J Pathol; 1999 May; 154(5):1423-9. PubMed ID: 10329595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies.
    Barrachina M; Castaño E; Dalfó E; Maes T; Buesa C; Ferrer I
    Neurobiol Dis; 2006 May; 22(2):265-73. PubMed ID: 16380264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased mitochondrial DNA deletions in substantia nigra dopamine neurons of the aged rat.
    Parkinson GM; Dayas CV; Smith DW
    Curr Aging Sci; 2014; 7(3):155-60. PubMed ID: 25612740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Bukhatwa S; Zeng BY; Rose S; Jenner P
    Brain Res; 2010 Apr; 1326():174-83. PubMed ID: 20176003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkin deficiency accelerates consequences of mitochondrial DNA deletions and Parkinsonism.
    Song L; McMackin M; Nguyen A; Cortopassi G
    Neurobiol Dis; 2017 Apr; 100():30-38. PubMed ID: 28042097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Damage in Mitochondrial DNA Associated with Parkinson's Disease.
    Martín-Jiménez R; Lurette O; Hebert-Chatelain E
    DNA Cell Biol; 2020 Aug; 39(8):1421-1430. PubMed ID: 32397749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.